Everhart Financial Group Inc. lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 21.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,666 shares of the company’s stock after selling 6,603 shares during the period. Everhart Financial Group Inc.’s holdings in Procter & Gamble were worth $3,535,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of PG. Halbert Hargrove Global Advisors LLC purchased a new stake in shares of Procter & Gamble in the third quarter valued at approximately $25,000. Saranac Partners Ltd purchased a new position in Procter & Gamble during the third quarter worth approximately $30,000. Corundum Trust Company INC acquired a new position in Procter & Gamble during the third quarter worth $32,000. Caitlin John LLC purchased a new stake in Procter & Gamble in the 3rd quarter valued at $34,000. Finally, Marquette Asset Management LLC purchased a new stake in Procter & Gamble in the 3rd quarter valued at $37,000. 65.77% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Procter & Gamble
In related news, CEO Gary A. Coombe sold 36,093 shares of the stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the completion of the transaction, the chief executive officer owned 34,994 shares of the company’s stock, valued at approximately $5,680,576.02. This trade represents a 50.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Marc S. Pritchard sold 95,903 shares of Procter & Gamble stock in a transaction that occurred on Friday, January 23rd. The shares were sold at an average price of $151.15, for a total transaction of $14,495,738.45. Following the completion of the sale, the insider owned 182,607 shares of the company’s stock, valued at $27,601,048.05. This trade represents a 34.43% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 348,618 shares of company stock worth $55,462,643. 0.20% of the stock is owned by company insiders.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Friday, January 23rd. The company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The firm had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. During the same period in the previous year, the firm earned $1.88 EPS. Procter & Gamble’s revenue was up 1.5% on a year-over-year basis. Equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. The ex-dividend date was Friday, January 23rd. Procter & Gamble’s dividend payout ratio is currently 62.67%.
Wall Street Analysts Forecast Growth
PG has been the topic of several analyst reports. Wells Fargo & Company reiterated an “overweight” rating and set a $177.00 price target on shares of Procter & Gamble in a report on Tuesday, February 17th. TD Cowen lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and upped their price objective for the company from $150.00 to $156.00 in a report on Tuesday, January 27th. UBS Group raised their price objective on shares of Procter & Gamble from $161.00 to $170.00 and gave the stock a “buy” rating in a research report on Friday, January 23rd. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Procter & Gamble from $176.00 to $171.00 and set a “buy” rating on the stock in a report on Monday, December 8th. Finally, JPMorgan Chase & Co. raised shares of Procter & Gamble from a “neutral” rating to an “overweight” rating and increased their price target for the company from $157.00 to $165.00 in a research note on Friday, January 23rd. Fourteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $168.33.
Check Out Our Latest Stock Analysis on PG
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
See Also
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
